SymBio Pharmaceuticals Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 1.28% vs -30.67% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 49.26% vs -98.38% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "236.50",
          "val2": "233.50",
          "chgp": "1.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1,294.00",
          "val2": "-2,341.10",
          "chgp": "44.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.00",
          "val2": "16.60",
          "chgp": "8.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.70",
          "val2": "3.20",
          "chgp": "15.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,218.50",
          "val2": "-2,401.40",
          "chgp": "49.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5,471.30%",
          "val2": "-10,027.80%",
          "chgp": "455.65%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -46.69% vs -56.12% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -24.59% vs -95.31% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,307.60",
          "val2": "2,452.90",
          "chgp": "-46.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4,440.70",
          "val2": "-3,877.00",
          "chgp": "-14.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "149.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-76.30",
          "val2": "-117.50",
          "chgp": "35.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4,776.20",
          "val2": "-3,833.50",
          "chgp": "-24.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,395.90%",
          "val2": "-1,580.60%",
          "chgp": "-181.53%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

236.50

233.50

1.28%

Operating Profit (PBDIT) excl Other Income

-1,294.00

-2,341.10

44.73%

Interest

18.00

16.60

8.43%

Exceptional Items

3.70

3.20

15.62%

Consolidate Net Profit

-1,218.50

-2,401.40

49.26%

Operating Profit Margin (Excl OI)

-5,471.30%

-10,027.80%

455.65%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 1.28% vs -30.67% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 49.26% vs -98.38% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,307.60

2,452.90

-46.69%

Operating Profit (PBDIT) excl Other Income

-4,440.70

-3,877.00

-14.54%

Interest

149.40

0.00

Exceptional Items

-76.30

-117.50

35.06%

Consolidate Net Profit

-4,776.20

-3,833.50

-24.59%

Operating Profit Margin (Excl OI)

-3,395.90%

-1,580.60%

-181.53%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -46.69% vs -56.12% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -24.59% vs -95.31% in Dec 2024

All Annual Results